Next Article in Journal
Structural Basis for (2R,3R)-Taxifolin Binding and Reaction Products to the Bacterial Chalcone Isomerase of Eubacterium ramulus
Next Article in Special Issue
Anxiolytic-like Effect of Inhaled Cinnamon Essential Oil and Its Main Component Cinnamaldehyde in Animal Models
Previous Article in Journal
Multi-Bioactivity of Protein Digests and Peptides from Oat (Avena sativa L.) Kernels in the Prevention of the Cardiometabolic Syndrome
Previous Article in Special Issue
Essential Oils and Their Compounds as Potential Anti-Influenza Agents
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 22
10.3390/molecules27227908
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway

by
Manar K. Alomair
,
Lama S. Alabduladheem
,
Marwah A. Almajed
,
Amjad A. Alobaid
,
Essraa A. R. Alkhalifah
,
Nancy S. Younis
and
Maged E. Mohamed
*
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(22), 7908; https://doi.org/10.3390/molecules27227908
Submission received: 2 November 2022 / Revised: 12 November 2022 / Accepted: 14 November 2022 / Published: 15 November 2022
(This article belongs to the Special Issue Biological Activity of Essential Oils)
Browse Figures
Versions Notes

Abstract

:
Extreme ethanol ingestion is associated with developing gastric ulcers. Achillea millefolium (yarrow) is one of the most commonly used herbs with numerous proven pharmacological actions. The goal of the hereby investigation is to explore the gastroprotective action of yarrow essential oil against ethanol-induced gastric ulcers and to reveal the unexplored mechanisms. Rats were distributed into five groups (n = 6); the control group administered 10% Tween 20, orally, for two weeks; the ethanol group administered absolute ethanol (5 mL/kg) to prompt gastric ulcer on the last day of the experiment. Yarrow essential oil 100 or 200 mg/kg + ethanol groups pretreated with yarrow oil (100 or 200 mg/kg, respectively), orally, for two weeks prior to gastric ulcer induction by absolute ethanol. Lanso + ethanol group administered 20 mg/kg lansoprazole, orally, for two weeks prior to gastric ulcer induction by ethanol. Results of the current study showed that ethanol caused several macroscopic and microscopic alterations, amplified lipid peroxidation, pro-inflammatory cytokines, and apoptotic markers, as well as diminished PGE2, NO, and antioxidant enzyme activities. On the other hand, animals pretreated with yarrow essential oil exhibited fewer macroscopic and microscopic modifications, reduced ulcer surface, and increased Alcian blue binding capacity, pH, and pepsin activity. In addition, yarrow essential oil groups exhibited reduced pro-inflammatory cytokines, apoptotic markers, and MDA, restored the PGE2 and NO levels, and recovered the antioxidant enzyme activities. Ethanol escalated Nrf2 and HO-1 expressions, whereas pretreatment of yarrow essential oil caused further intensification in Nrf2 and HO-1. To conclude, the current study suggested yarrow essential oil as a gastroprotective agent against ethanol-induced gastric lesions. This gastroprotective effect could be related to the antioxidant, anti-inflammatory, and anti-apoptotic actions of the essential oil through the instigation of the Nrf2/HO-1 pathway.

1. Introduction

One of the most common gastrointestinal tract diseases is the gastric ulcer [1]. These types of ulcers develop as a result of the disproportion between destructive and defensive features in the gastric mucosa [2]. The gastric ulcer that arises with alcohol or NSAID consumption is associated with physiological and/or psychological stress [3]. Ethanol is a gastric mucosal destructive factor [4] as gastric exposure to ethanol promptly stimulates neutrophils, leading to oxidative stress by intensifying the generation of reactive oxygen species (ROS) as well as the pro-inflammatory cytokines, resulting in mucosal injuries and damage. Several studies established that pro-inflammatory cytokines and oxidative homeostasis have an imperative influence on alcohol-induced gastric ulcer [5]. The nuclear factor-erythroid 2 related factor 2 (Nrf2) signaling pathway protects cells from oxidative damage by triggering endogenous antioxidant enzymes [6]. Under normal physiological conditions, Nrf2 is bound to the negative regulator Keap1, forming a complex which remains inactively in the cytoplasm or degrades by proteases [7]. Under oxidative stress conditions, Nrf2 dissociates from the cytoplasmic Keap1 complex and translocates to the nucleus causing the transcriptional initiation of phase II antioxidant enzymes’ genes, including the Heme Oxygenase-1 (HO-1) [8]. Several FDA-approved medications have been used in the management of gastric ulcers. Nevertheless, these drugs are associated with several adverse effects, including the increased risk of hospital and community-acquired pneumonia, arrhythmia, gynecomastia, and hematopoietic changes [2]; hence, the search for new compounds is essential. These new anti-gastric ulcer compounds ought to have several characteristics, including the capability to mitigate gastric inflammation and oxidative stress, as well as to boost endogenous gastric mucosa’s defensive ability.
Medicinal plants and their components have numerous biological actions. The Achillea genus comprises over a hundred species and subspecies, which are dispersed all over the world [9,10,11]. Achillea millefolium, family Asteraceae, widely known as “yarrow”, is a frequently used herb in the Middle East as a fresh or dried herb [12,13,14]. It is utilized in different forms, such as in tea mixtures, tablets, tinctures, and ointments, among other formulations [9,15]. This herb has been traditionally used as an astringent, antiseptic, and to manage gastrointestinal complaints, diminish menstrual contractions and inconsistency, and to stimulate wound, burn, and ulcer healing [13,16]. Commission E approved the ingestion of yarrow for appetite loss and dyspeptic disorders. Furthermore, it approved the external usage of yarrow as a sitz bath for painful, cramp-like disorders occurring in the female pelvis [9]. In the USA, yarrow is utilized as a diaphoretic constituent in the typical cold and flu formulations, and in topical styptic preparations [9]. A double-blind clinical study showed that yarrow oil exhibited an anti-inflammatory activity for skin application and prevented hypertrophic scarring in humans, proposing yarrow oil as a promising base to be used in the phytopreparations designed for the dermatological application [16]. The yarrow essential oil (YEO) exhibited several pharmacological activities such as anti-leishmanial [17], antimalarial, phytotoxic, insecticidal [18], anti-inflammatory [19], anti-hemorrhoidal [20], anti-oxidant [14], anti-microbial [21], and cytotoxic and proapoptotic properties [22]. Additionally, our laboratory formerly documented the potent protective action of YEO-regulated NF-κB and PPAR-γ pathways, which protected against dextran sulfate sodium (DSS) induced ulcerative colitis (UC) [12]. Another study suggested YEO be effective as an antitumor agent, via modulating the activity of peritoneal macrophages [23].
Yet, the protective effect of YEO against gastric ulcers is unclear. Therefore, in the current investigation, we tried to disclose the gastroprotective action of YEO against gastric ulcers caused by ethanol ingestion and reveal part of the mechanisms of action underlying.

2. Results

2.1. Effect of YEO against Ethanol-Induced Gastric Ulcers

2.1.1. Macroscopic Assessment of Gastric Necrotic Damage

Illustrative images of stomachs are shown in Figure 1a. The macroscopic examination of normal rats’ stomachs displayed entirely healthy pink color gastric mucosa with typical gastric mucosal thickening. The gross evaluation of ulcerated stomachs exhibited severe tissue damage as well as visible hemorrhagic mucosal lesions that presented as extended bands of hemorrhagic injuries comparable to the stomach long axis (Figure 1a, red arrowhead). Pretreatment with YEO resulted in less stomach damage as well as fewer hemorrhagic mucosal lesions. Lansoprazole (positive control) pretreated animals exhibited minor hemorrhagic vascular, but the gastric mucosa was still congested and swollen. The macroscopic gastric damage scores are shown in Figure 1b.

2.1.2. Microscopic Evaluation

Normal animals presented intact gastric mucosa with no signs of hemorrhages, congestion, or mucosal epithelium disturbance, Figure 2a. Ethanol administration resulted in a substantial variation in the epithelium, including hemorrhagic injury (Figure 2b) and epithelial cell loss (Figure 2c), as well as edema with leucocytes (Figure 2d). Figure 2a signifies necrotic injuries infiltrated profoundly into the mucosa and expanded edema of the submucosal layer (blue arrows). Interruption of the epithelium (black arrowhead) and leucocyte infiltration (green arrowhead) were revealed in ulcerated animals. However, pretreatment with YEO and lansoprazole considerably lessened ethanol-induced epithelial destruction, contributing to the conservation of the wall structure. These macroscopic and microscopic histological investigations revealed that YEO might ameliorate ethanol-induced gastric mucosal destruction.

2.2. Effect of YEO on Gastric Ulcer Area and Mucus Content

Gastric ulcer surface area increased significantly in ethanol-administered animals, whereas animals pretreated with YEO and lansoprazole significantly demonstrated reduced ulcer surface area compared to the ethanol group (Table 1). Alcian blue is used as a marker of the mucus extent in the mucosa [24]. Rats with gastric injuries induced by ethanol presented a substantial reduction in Alcian blue binding ability of the mucosa (Table 1) when correlated to the control. On the contrary, pretreatment with YEO (100 or 200 mg/kg) and lansoprazole significantly amplified the Alcian blue binding ability to the mucosa compared to those of the ethanol alone group.

2.3. Action of YEO on the Gastric Secretion Indices

Ethanol ingestion resulted in a significant reduction in pH with a resultant escalation in gastric volume when linked to the control group. Pretreatments with YEO (100 and 200 mg/kg) produced a significant intensification in pH associated with a decline in gastric volume when related to ulcerated rats (Table 2). Concurrent ethanol administration decreased the pepsin activity of gastric juice in the ethanol-induced ulcerated animals by 2.72-fold when linked to the control, whereas pepsin activity was increased in groups pretreated with YEO (100 and 200 mg/kg) compared to the ethanol alone animals. These outcomes exposed that YEO amended ethanol-induced changes in gastric pH and volume and in the pepsin activity of gastric juice.

2.4. Action of Yarrow Oil on the Nrf2/HO-1 Pathway

Due to the imperative role of Nrf2/HO-1 signaling pathway in protecting gastric cells from oxidative damage, Nrf2 and HO-1 were evaluated using immunohistochemical and PCR. Immunohistochemical and PCR results (Figure 3) displayed that the ethanol resulted in a slightly intensified expression of Nrf2 and HO-1. However, pretreatment of YEO at the dose of 100 and 200 mg/kg dose-dependently up-regulated expressions of Nrf2 and HO-1 in ethanol-administered rats.

2.5. Action of YEO on Serum Inflammatory Cytokines

As presented in Figure 4, ethanol considerably (p < 0.05) amplified the pro-inflammatory cytokines serum levels reaching a 2.37-fold increase for interleukin-1β (IL-1β), 2.1-fold rise for IL-6, and 2.47-fold upsurge for TNF-α when linked to the control group. However, these pro-inflammatory cytokines levels were markedly (p < 0.05) declined in the groups pretreated with lansoprazole or YEO (100 and 200 mg/kg).

2.6. Action of YEO on Gastric Defensive Factors

The outcomes of the current investigation disclosed that ethanol administered significantly decreased the PGE2 by 3.9-fold change (Figure 4d). Meanwhile, pretreatment with YEO (100 and 200 mg/kg) and lansoprazole restored the PGE2 level resulting in a percentage change of 35.66%, 70.48%, and 90.70%, respectively, when related to the ethanol group. As for NO, the serum and gastric levels of NO (Figure 4e,f) diminished in animals administered ethanol. Whereas the serum and gastric levels of nitric oxide amplified in the animals pretreated with YEO.

2.7. Action of YEO on Serum and Gastric Levels of Oxidative Stress Markers

Ethanol-induced gastric injury is frequently pursued with oxidative stress as well as antioxidant enzyme depletion. Therefore, we examined one oxidative stress biomarker (MAD) and antioxidant enzyme activities (GSH, SOD, catalase), Figure 5. The results indicated that serum and gastric MDA (Figure 5a,b) were significantly elevated while GSH, SOD, and catalase activities were diminished. While the pretreatment with YEO and lansoprazole significantly lowered the serum and gastric levels of MDA. Furthermore, YEO retrieved the antioxidant enzyme GSH (Figure 5c,d), SOD (Figure 5e,f), and catalase (Figure 5g,h) activities in the gastric and serum, respectively, which were diminished by ethanol administration.

2.8. Effect of YEO on the Apoptosis Markers

The gene expression of Bcl-2 was reduced, while Bax gene expression was elevated in the ulcer group when related to control animals. Upon the pretreatment with YEO (100 and 200 mg/kg) and lansoprazole, the gene expression of Bcl-2 was up-regulated, showing percentage changes of 102.63%, 151.68%, and 223.26%, respectively, related to the ethanol group, Figure 6. As for Bax gene expression, it was substantially lowered in groups pretreated with YEO and lansoprazole showing a percentage reduction of 22.86%, 39.98%, and 57.91%, respectively, when related to ethanol-induced gastric injuries, Figure 6. Regarding caspase-3 and 9, they were elevated in ulcerated animals, but in the groups pretreated with YEO or lansoprazole, caspase-3 and 9 were significantly lowered as demonstrated in Figure 6.

3. Discussion

Uncontrolled consumption of alcohol and spirits has increased the risk of gastric ulcers all over the world [25]. Extreme alcohol ingestion causes injury to the stomach by damaging the mucosal barrier integrity [26]. Gastric ulcers are caused by the reduction in the mucus-covering layer of the stomach, as a consequence of excess acid or pepsin secretion. Many factors may contribute to this corrosive development, such as infection with Helicobacter pylori, smoking, the misuse of alcohol, or the prolonged use of NSAIDs [27]. Many plants’ essential oils or their components demonstrated very promising activities against various types of ulcers and could be looked at as potential antiulcer agents [28,29,30].
The existing investigation examined the gastroprotective actions of YEO against ethanol-induced gastric ulcers in rats. Oral ingestion of ethanol caused numerous macroscopic alterations as well as microscopic alterations, confirming the injurious actions of ethanol. Ethanol prompts gastric lesions as it infiltrates and digests the gastric wall with its proteolytic and hydrolytic activities [31]. Earlier studies showed several microscopic and macroscopic modifications associated with the ingestion of ethanol [5,32,33]. Furthermore, ethanol-administered animals exhibited amplified gastric ulcer surface area and gastric volume accompanied by a substantial reduction in Alcian blue binding capacity to the mucosa, pH, and pepsin activity of gastric juice. Amplified hydrogen ion concentration is a destructive element facilitating gastric damage; thus, the gastric pH of ethanol-administered rats was reduced, as revealed by the current study and by previous studies as well [34]. Animals pretreated with YEO alleviated the ethanol-induced microscopic and macroscopic alteration, contributing to the preservation of the gastric wall structure. In addition, animals pretreated with YEO displayed reduced ulcer surface and gastric volume, complemented by an increase in the Alcian blue binding ability of the mucosa, pH value, and pepsin activity. These macroscopic and microscopic examinations, together with these outcomes, implied that YEO might ameliorate ethanol-induced gastric mucosal injuries.
One of the proposed mechanisms through which YEO may act is the Nrf2/HO-1 pathway. Transcription factor, nuclear factor-erythroid 2 related factor 2 (Nrf2) plays a crucial part in cell defensive mechanisms via maintaining the cell antioxidants ability [6], inhibiting pro-inflammatory signaling by reducing NF-κB [7]. The subsequential elements of Nrf2 signaling embrace the antioxidant enzymes HO-1, CAT, and GSH. It was reported that heme oxygenase-1 (HO-1) retains defensive qualities against ethyl alcohol-induced ulcers via the Nrf2/HO-1 pathway [8,35]. The immunohistochemical and gene expression results exposed that the ethanol displayed an escalated expression of the Nrf2 and HO-1. Furthermore, pretreatment with YEO causes further up-regulating in the expressions of Nrf2 and HO-1. A preceding study showed that yarrow oil suppressed the inflammatory responses of LPS-stimulated RAW 264.7 macrophages via the down-regulating of the HO-1 expression [36].
Extreme ingestion of ethanol provokes inflammation with the release of inflammatory cytokines as well as macrophages and lymphocytes infiltrated to the inflammation site [37,38]. The infiltrating of immune cells, especially neutrophils results in connexin destruction and mucosal barrier damage, which ultimately leads to gastritis [39]. Furthermore, these cytokines amplified oxygen-derived free radicals, thus aiding to the development of gastric ulcers [40,41]. Consistent with the preceding results, our results indicated that ethanol amplified the cytokines in the serum levels, including IL-1β, IL-6 and TNF-α. However, these pro-inflammatory cytokines levels were reduced by the pretreatment with YEO. Likewise, a previous study accomplished in our laboratory proved that YEO depressed ulcerative colitis via reducing of the inflammatory signs. It down-regulated NF-κB, TNF-α expression, IL-6 serum level as well as up-regulated peroxisome proliferator-activated receptor gamma (PPAR-γ), and transforming growth factor-β expression and restored IL-10 level [12]. In addition, YEO suppressed the inflammation associated with LPS-stimulated RAW 264.7 macrophages via the down-regulating the inducible iNOS, COX-2, TNF-α, IL-6 and HO-1 expression [36]. In addition, yarrow oil exhibited potent anti-inflammatory potential, especially in topical application [16].
PGE2 is one of the gastric mucosa defensive factors as it regulates gastric acid secretion, stabilizes the mast cell membrane, and stimulates the repairing measures, thus having a substantial part in the ulcer prevention as well as healing [3]. Therefore, PGE2 diminished level within the gastric mucosa results in ulceration and/or alleviation of the already existing ulcers [42,43]. Results of the current study disclosed that ethanol ingestion declined PGE2 level. Another gastric mucosa defensive factor is NO, which stimulates the mucus and bicarbonate synthesis, maintains the blood flow, and inhibits inflammation [44]. Consistent with previous reports [37,41], the results showed that serum and gastric NO were significantly reduced in ethanol-induced gastric ulcers, whereas pretreatment with YEO restored both serum PGE2 and serum and gastric NO levels.
An established relationship exists between oxidative stress during the development of ethanol-induced gastric ulcer [37]. ROS reacts with lipids to produce lipid peroxides causing extensive damage [45]. In the existing investigation, the amplified production of free radicals was associated with the membrane destruction detected in ethanol-induced gastric ulcers, as evidenced by the elevated serum and gastric lipid peroxidation (MDA). ROS are usually trapped by the natural antioxidant protective system, which compromises antioxidant enzymes, e.g., SOD and CAT [46]. Diminished GSH, SOD, and CAT enzyme activities contribute to ethanol-induced oxidative damage [47]. As revealed in the outcomes of the present study, ethanol exposure reduced GSH, SOD, and CAT activities. Conversely, YEO lowered the serum and gastric levels of MDA and restored the antioxidant enzyme GSH, SOD, and CAT activities in both gastric tissues and serum, identifying YEO’s antioxidant potential and further complying with the gastroprotective potential against ethanol-induced ulcers. Previously, YEO suppressed LPS-stimulated RAW 264.7 macrophage [36], via reducing NO and superoxide anion synthesis, lipid peroxidation, and glutathione content [36].
Ethanol-induced oxidative stress, together with inflammation, initiates the apoptosis intrinsic pathway resulting in activating Bax and deactivating Bcl2 [48,49]. The activated Bax translocates into the mitochondria, triggering the discharge of other pro-apoptotic elements to the cytoplasm, which initiates caspase 3, resulting in cell death [50,51]. Results showed that the gene expression of Bcl-2 was reduced, whereas Bax gene expression and caspase-3 and 9 were both elevated in the ulcer group. In contrast, pretreatment with YEO amplified the gene expression of Bcl-2 and reduced Bax gene expression as well as caspase-3 and 9 levels indicating restraining the apoptosis process arising with ethanol administration.
The phytochemical components of YEO may vary quantitatively in the relative percentage of each component; however, the essential oil qualitatively processes almost the same components. The chemical composition of our YEO sample, used in the current study, was revealed in an earlier study [12] by our laboratory to contain 6 components as major; Germacrene D (26.15%), β-caryophyllene (10.35%), and chamazulene (10.04%), as the major sesquiterpene; sabinene (14.28%), β-pinene (11.40%), and borneol (5.26%), as major monoterpenes. These major components may contribute, alone, or in combination, to the protective effect of YEO, discovered in the hereby study. These components may exert this protective effect through their antioxidant, anti-inflammatory, or antiapoptotic action. For example, chamazulene is recognized for its anti-inflammatory ability [52], and so is β-caryophyllene [53] and Germacrene D [54]. β-caryophyllene and germacrene D diminished the concentrations of the inflammatory mediators IL-1β, IL-6, and TNF-α, in LPS-stimulated cells [55]. Both Sabinene [56] and Borneol [57] inhibited the production of NO and lowered the levels of the inflammatory markers, including NO, TNF-α, and IL-6.

4. Materials and Methods

4.1. Plant Materials, and YEO Isolation

The plant materials’ collection and manipulation were described, as previously published by our laboratory [12]. Briefly, the whole yarrow plant (Achillea millefolium L., family Asteraceae) was collected, identified, dried, and exposed to hydro-distillation via Clevenger-type apparatus for 3 h. The volatile oil fraction was recovered and dried over anhydrous sodium sulfate and stored at 4° C until use. The obtained YEO was analyzed using gas chromatography, and the results were previously published in [12].

4.2. Experimental Animals and Ethical Issues

King Faisal University Research Ethics Committee (KFU-REC) granted its ethical authorization with approval number KFU-REC-2022-APR-EA000566. The study procedure was permitted by KFU-REC, which approved all the procedures. Healthy male adult Wistar rats were included in this experiment. Rats were retained under optimal standardized laboratory conditions at 25 ± 2 °C in a 12-h light-dark cycle at the College of Medicine animal house, King Faisal University.

4.3. Experimental Design

Wistar rats (aged 6–8 weeks and weighing 200–220 g) were distributed randomly into five groups (n = 6), and the experiment was accomplished as mentioned earlier [33]. Group 1 (control group), in which rats were given 10% Tween 20 (the vehicle) orally for two weeks. Group 2, or ethanol group, in which rats were given absolute ethanol (5 mL/kg) orally to produce peptic ulcerated animals on the last day of the experiment. YEO 100 and 200 mg/kg + ethanol (Group 3 and 4) in which animals were pretreated with YEO 100 and 200 mg/kg, respectively, orally dissolved in 10% Tween 20, for two weeks preceding the inauguration of gastric ulcer via ethanol. Group 5 (Lanso + ethanol) represents the reference control group, in which animals were pretreated with 20 mg/kg lansoprazole dissolved 10% Tween 20 orally for two weeks preceding the inauguration of gastric ulcer via ethanol. The doses of YEO were chosen depending on a study that was implemented in our laboratory [12]. A preliminary study was done to investigate the therapeutic doses of YEO in experimental animals, using concentrations from 1 to 500 mg/kg, from which these two doses were chosen to continue the investigation.

4.4. Induction of Gastric Ulcer

Former to the ethanol administration, animals were fasted for 24 h, with free access to drinking water until 2 h before ethanol administration. Gastric ulcer was prompted by absolute ethanol (5 mL/kg) using oral gavage. Four hours after absolute ethanol administration, animals were anesthetized using pentobarbital sodium (35 mg/kg, i.p.). Blood was collected from the abdominal aorta, and centrifuged at 4000 rpm for 15 min to acquire serum which was stored at −80 °C. Then, the rats were sacrificed, the stomachs were separated and drained into centrifuge tubes to measure gastric section indices. Stomachs were washed with ice-cold saline for macroscopic examination, gastric barrier mucus quantitative estimation, and to prepare stomach homogenate for subsequent analysis.

4.5. Gastric Mucosal Lesion Macroscopic Examination

Gastric macroscopic injury was photographed and evaluated by blinded histopathologist and recorded as mentioned before [58]. The macroscopic gastric damage score used was as follows: 0 indicating zero lesions, 1–2 signifying small lesions, 3–4 signifying small ulcer, 5–6 indicating large ulcer, and 7 representing full of ulcers. The ulcer’s length and width were assessed using a planimeter (10 × 10 mm2) using a dissecting microscope. The gastric ulcerated area was assessed via counting the sum of small squares underlying the ulcer area. The ulcer area (UA) and the inhibition percentage (I %) were estimated as mentioned before [32,33] using the formulas:
Ulcer area UA (mm2) = number of small squares × 4 × 1.8.
The inhibition percentage (I%) =
((ulcer area of control − ulcer area of treated)/ulcer area of control) × 100

4.6. Assessment of Gastric Indices

The stomach contents were drained into centrifuge tubes for volume and pH determination. The stomach content drain was centrifuged (4000 rpm, 10 min), and the obtained supernatant pH was measured using a digital pH meter. In addition, pepsin activity was estimated using the stomach secretion.

4.7. Gastric Barrier Mucus Quantitative Estimation

The gastric wall mucus was assessed using Alcian blue, as mentioned before [59]. The stomach’s glandular part was weighed and mixed with 10 mL of 0.1% w/v Alcian blue solution for 2 h, and the extra color was removed by washing the solution two times using 0.25 M sucrose. Alcian blue dye mixed with gastric wall mucus was extracted via irregular shaking for 1 min every 30 min for 2 h with 0.5 M magnesium chloride (MgCl2). Diethyl ether is added to the blue concentrate to obtain an emulsion which was centrifuged at 3000× g for 10 min. The fluid layer absorbance was assessed at 580 nm. The Alcian blue extent for every gm of wet glandular tissue was, afterward, calculated.

4.8. Histopathological and Immunohistochemistry (IHC) Microscopically Examinations

The gastric tissues were fixed with 10% (v/v) formalin and paraffin-embedded to obtain paraffin-embedded gastric tissue sections, which will be used in histopathological and IHC evaluations.
Gastric sections (5 µm) were stained using hematoxylin and eosin (H&E) for histological assessment. The pathological fluctuations were recognized using a microscope by a blinded histopathologist. The hemorrhagic damage, epithelial cell loss, and edema with leucocytes were recorded, and the lesions’ extent was categorized from 1 to 5 according to the severity. One indicated the minimal degree of lesion (less than 1%), two signified slight (1–25%), three demonstrated moderate (26–50%) degree of lesion, four implied moderate/severe (51–75%), and five showed severe/high (76–100%) degree of lesion.
For the IHC procedure, the expression of Nrf2 and HO-1 were determined. Briefly, stomach sections were blocked using 3% H2O2 in methanol (21–25 °C, 30 min) and washed with phosphate-buffered saline three times. The gastric sections were incubated with Nrf2 and HO-1 antibodies (1:100, Thermo Fisher Scientific) overnight at 4 °C, followed by goat anti-rabbit-horseradish peroxidase (HRP) conjugated IgG antibody for 1 h at 37 °C. The gastric sections were settled with 1% diaminobenzidine, counterstained with 1% hematoxylin, and mounted. The gastric sections were assessed using a microscope built-in with a digital camera. The area of the IHC reaction was chosen, and then the average optical density in the designated area was assessed. Positive cells were calculated with ×400 magnification, spotting 10 sequential fields for each animal. NIS-Elements software was utilized for quantitative analysis.

4.9. Gastric Homogenate Preparation

The gastric tissue was divided into small parts, homogenized by a Teflon homogenizer and centrifuged (4500 rpm, 15 min, 4 °C) to obtain supernatant. The obtained supernatant was used for the oxidative stress, antioxidant enzymes, caspase 3, and caspase 9 measurements. The entire experiment was performed at 4 °C.

4.10. Gene Expression Experiments (Real-Time PCR)

Real-time PCR was performed according to the technique used in our laboratory and described elsewhere [60]. Quantification analyses were completed via Opticon-2 Real-Time PCR reactor. Step PE Applied Biosystems analyzed real-time PCR results. Expression of the target genes were assessed and related to the reference gene (β-actin). β-actin expression was used for sample normalization, where the 2−ΔΔCT equation was used for relative expression determination. The primers used are as follows: Nrf2 (NM_031789.2) F: 5′-CATTTGTAGATGACCATGAGTCGC-3′, R: 3′-ATCAGGGGTGGTGAAGACTG-5′; HO-1 (NM_ 012580.2) F: 5′-GTGCACATCCGTGCAGAGAA-3′, R: 3′-GTGCACATCC GTGCAGAGA A-5′; Bcl-2 (NM_016993.1) F: 5′-CCGGGAGATCGTGATGAAGT -3′, R: 3′-ATCCCAGCCTCCGTTATCCT-5′; Bax (NM_017059.2) F: 5′-GTGGTTGCCCTCTTCTAC TTTG-3′, R: 3′-CACAAAGATGGTCACTGTCTGC-5′; β-actin (NM_0 3144.3) F: 5′-TGACAGGATGCAG AAG GAGA-3′, R: 3′-TA GAGCCACCA ATCCACACA-5′.

4.11. The Assessment of Gastric Mucosa Defensive Factors

Serum levels of prostaglandin E2 (PGE2, ab287802) and serum and gastric levels of nitric oxide (NO, ab65328) were measured using ELISA kits that were acquired from Abcam Co., Eugene, OR, USA.

4.12. The Assessment of the Inflammatory Cytokines Markers

Serum levels of inflammation cytokines markers, comprising TNF-α (ab46070), IL-1β (ab100768), and IL-6 (ab100772), were evaluated using ELISA kits, which were obtained from Abcam Co., Eugene, OR, USA.

4.13. The Assessment of Oxidative Stress Status and Antioxidant Enzymes Activities

Serum and gastric levels of malondialdehyde (MDA; ab238537) were measured using an ELISA kit acquired from Abcam Co., Eugene, OR, USA. The serum and gastric levels of reduced glutathione (GSH; MBS706914), superoxide dismutase (SOD; MBS036924), and catalase (MBS726781) were assessed using ELISA kits, obtained from My BioSource (San Diego, CA, USA).

4.14. The Assessment of Apoptotic Markers

Cleaved caspase-3 (KHO1091) was obtained from Thermo Fisher Scientific Inc., Waltham, MA, USA, whereas caspase-9 (LS-F4141) was attained from Biocompare, CA, USA.

4.15. Statistical Analysis

Data in the current study are displayed as mean ± SD. For numerous associations, one-way ANOVA followed by Tukey–Kramer as a post hoc test was accomplished. Level of probability of 0.05 or less was utilized as the level of significance (p < 0.05). All analyses were executed via Graph Pad software v. 8.

5. Conclusions

The current study presented that YEO exerted a considerable gastroprotective action against ethanol-induced gastric lesions. This gastroprotective potential may be related to the enrichment of the antioxidant protective system and to deterring inflammation through decreasing IL-1β, IL-6, and TNF-α and detaining apoptosis via regulating Bax, Bcl-2, and caspase 3 and 9. YEO exhibited antioxidant, anti-inflammatory, and anti-apoptotic activities, possibly through instigating the Nrf2/HO-1-related pathway. This study adds to the pool of YEO pharmacological activities and reveals part of the underlying mechanism of action. This study could be implemented in an anti-alcoholism program through using YEO as a protective agent against misused-alcohol-induced gastric ulcers in patients at risk.

Author Contributions

E.A.R.A., A.A.A., M.A.A., M.K.A., L.S.A., N.S.Y. and M.E.M.; methodology, E.A.R.A., A.A.A., M.A.A., M.K.A., L.S.A., N.S.Y. and M.E.M.; validation, E.A.R.A., A.A.A., M.A.A., M.K.A., L.S.A., N.S.Y. and M.E.M.; resources, E.A.R.A., A.A.A., M.A.A., M.K.A., L.S.A., N.S.Y. and M.E.M.; writing—original draft preparation, E.A.R.A., A.A.A., M.A.A., M.K.A. and L.S.A.; writing—review and editing, N.S.Y. and M.E.M.; supervision, N.S.Y. and M.E.M.; project administration, N.S.Y. and M.E.M.; funding acquisition, N.S.Y. and M.E.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia [GRANT737].

Institutional Review Board Statement

King Faisal University Research Ethics Committee (KFU-REC) granted its ethical authorization with approval no KFU-REC-2022-APR-EA000566. The study procedure was permitted by KFU-REC, which approved all the procedures.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors thanks Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia for financial support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Li, W.S.; Lin, S.C.; Chu, C.H.; Chang, Y.K.; Zhang, X.; Lin, C.C.; Tung, Y.T. The Gastroprotective Effect of Naringenin against Ethanol-Induced Gastric Ulcers in Mice through Inhibiting Oxidative and Inflammatory Responses. Int. J. Mol. Sci. 2021, 22, 11985. [Google Scholar] [CrossRef] [PubMed]
  2. Schubert, M.L. Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion. Curr. Opin. Gastroenterol. 2017, 33, 430–438. [Google Scholar] [CrossRef] [PubMed]
  3. Choi, Y.J.; Kim, N.; Lee, J.Y.; Nam, R.H.; Chang, H.; Seo, J.H.; Kang, K.K.; Kim, H.J.; Choi, Y.J.; Lee, H.S.; et al. Protective effects of garlic extract, PMK-S005, against nonsteroidal anti-inflammatory drugs-induced acute gastric damage in rats. Dig. Dis. Sci. 2014, 59, 2927–2934. [Google Scholar] [CrossRef] [PubMed]
  4. Yu, C.; Mei, X.T.; Zheng, Y.P.; Xu, D.H. Gastroprotective effect of taurine zinc solid dispersions against absolute ethanol-induced gastric lesions is mediated by enhancement of antioxidant activity and endogenous PGE2 production and attenuation of NO production. Eur. J. Pharmacol. 2014, 740, 329–336. [Google Scholar] [CrossRef]
  5. Song, J.W.; Seo, C.S.; Kim, T.I.; Moon, O.S.; Won, Y.S.; Son, H.Y.; Son, J.K.; Kwon, H.J. Protective Effects of Manassantin A against Ethanol-Induced Gastric Injury in Rats. Biol. Pharm. Bull. 2016, 39, 221–229. [Google Scholar] [CrossRef] [Green Version]
  6. Yanaka, A. Role of NRF2 in protection of the gastrointestinal tract against oxidative stress. J. Clin. Biochem. Nutr. 2018, 63, 18–25. [Google Scholar] [CrossRef] [Green Version]
  7. Zhou, D.; Yang, Q.; Tian, T.; Chang, Y.; Li, Y.; Duan, L.R.; Li, H.; Wang, S.W. Gastroprotective effect of gallic acid against ethanol-induced gastric ulcer in rats: Involvement of the Nrf2/HO-1 signaling and anti-apoptosis role. Biomed. Pharmacother. 2020, 126, 110075. [Google Scholar] [CrossRef]
  8. Zhang, Y.; Jia, J.; Ding, Y.; Ma, Y.; Shang, P.; Liu, T.; Hui, G.; Wang, L.; Wang, M.; Zhu, Z.; et al. Alpha-boswellic acid protects against ethanol-induced gastric injury in rats: Involvement of nuclear factor erythroid-2-related factor 2/heme oxygenase-1 pathway. J. Pharm. Pharmacol. 2016, 68, 514–522. [Google Scholar] [CrossRef]
  9. Nemeth, E.; Bernath, J. Biological activities of yarrow species (Achillea spp.). Curr. Pharm. Des. 2008, 14, 3151–3167. [Google Scholar] [CrossRef]
  10. Mainka, M.; Czerwińska, M.E.; Osińska, E.; Ziaja, M.; Bazylko, A. Screening of Antioxidative Properties and Inhibition of Inflammation-Linked Enzymes by Aqueous and Ethanolic Extracts of Plants Traditionally Used in Wound Healing in Poland. Antioxidants 2021, 10, 698. [Google Scholar] [CrossRef]
  11. Bader, A.; AlQathama, A.; Cioni, P.L.; Ceccarini, L.; Abdelhady, M.I.S.; Al-Shareef, W.; Ascrizzi, R.; Flamini, G. Essential Oil Biodiversity of Achillea ligustica All. Obtained from Mainland and Island Populations. Plants 2022, 11, 1054. [Google Scholar] [CrossRef]
  12. Mohamed, M.E.; Elsayed, S.A.; Madkor, H.R.; Eldien, H.M.S.; Mohafez, O.M. Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways. Intest. Res. 2021, 19, 194–205. [Google Scholar] [CrossRef]
  13. Salehi, B.; Selamoglu, Z.; Sevindik, M.; Fahmy, N.M.; Al-Sayed, E.; El-Shazly, M.; Csupor-Löffler, B.; Csupor, D.; Yazdi, S.E.; Sharifi-Rad, J.; et al. Achillea spp.: A comprehensive review on its ethnobotany, phytochemistry, phytopharmacology and industrial applications. Cell. Mol. Biol. 2020, 66, 78–103. [Google Scholar] [CrossRef]
  14. Toplan, G.G.; Taşkın, T.; İşcan, G.; Göger, F.; Kürkçüoğlu, M.; Civaş, A.; Ecevit-Genç, G.; Mat, A.; Başer, K.H.C. Comparative Studies on Essential Oil and Phenolic Content with In Vitro Antioxidant, Anticholinesterase, Antimicrobial Activities of Achillea biebersteinii Afan. and A. millefolium subsp. millefolium Afan. L. Growing in Eastern Turkey. Molecules 2022, 27, 1956. [Google Scholar] [CrossRef]
  15. Gaweł-Bęben, K.; Strzępek-Gomółka, M.; Czop, M.; Sakipova, Z.; Głowniak, K.; Kukula-Koch, W. Achillea millefolium L. and Achillea biebersteinii Afan. Hydroglycolic Extracts–Bioactive Ingredients for Cosmetic Use. Molecules 2020, 25, 3368. [Google Scholar] [CrossRef]
  16. Tadić, V.; Arsić, I.; Zvezdanović, J.; Zugić, A.; Cvetković, D.; Pavkov, S. The estimation of the traditionally used yarrow (Achillea millefolium L. Asteraceae) oil extracts with anti-inflamatory potential in topical application. J. Ethnopharmacol. 2017, 199, 138–148. [Google Scholar] [CrossRef]
  17. Santos, A.O.; Santin, A.C.; Yamaguchi, M.U.; Cortez, L.E.; Ueda-Nakamura, T.; Dias-Filho, B.P.; Nakamura, C.V. Antileishmanial activity of an essential oil from the leaves and flowers of Achillea millefolium. Ann. Trop. Med. Parasitol. 2010, 104, 475–483. [Google Scholar] [CrossRef]
  18. Bader, A.; Panizzi, L.; Cioni, P.L.; Flamini, G. Achillea ligustica: Composition and antimicrobial activity of essential oils from the leaves, flowers and some pure constituents. Cent. Eur. J. Biol. 2007, 2, 206–212. [Google Scholar] [CrossRef]
  19. Chagas-Paula, D.A.; Oliveira, T.B.; Faleiro, D.P.V.; Oliveira, R.B.; Da Costa, F.B. Outstanding anti-inflammatory potential of selected Asteraceae species through the potent dual inhibition of cyclooxygenase-1 and 5-lipoxygenase. Planta Med. 2015, 81, 1296–1307. [Google Scholar] [CrossRef] [Green Version]
  20. Caliskan, U.K.; Aka, C.; Oz, M.G. Plants Used in Anatolian Traditional Medicine for the Treatment of Hemorrhoid. Rec. Nat. Prod. 2017, 11, 235–250. [Google Scholar]
  21. Candan, F.; Unlu, M.; Tepe, B.; Daferera, D.; Polissiou, M.; Sökmen, A.; Akpulat, H.A. Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae). J. Ethnopharmacol. 2003, 87, 215–220. [Google Scholar] [CrossRef]
  22. Abdalla, A.N.; Shaheen, U.; Abdallah, Q.M.A.; Flamini, G.; Bkhaitan, M.M.; Abdelhady, M.I.S.; Ascrizzi, R.; Bader, A. Proapoptotic Activity of Achillea membranacea Essential Oil and Its Major Constituent 1,8-Cineole against A2780 Ovarian Cancer Cells. Molecules 2020, 25, 1582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Lopes, F.; Benzatti, F.; Junior, C.; Moreira, R.; Carlos, I. Effect of the essential oil of Achillea millefolium L. in the production of hydrogen peroxide and tumor necrosis factor-α in murine macrophages. Rev. Bras. Cienc. Farm. 2005, 41, 401–405. [Google Scholar] [CrossRef] [Green Version]
  24. Komuro, Y.; Ishihara, K.; Ishii, K.; Ota, H.; Katsuyama, T.; Saigenji, K.; Hotta, K. A separating method for quantifying mucus glycoprotein localized in the different layer of rat gastric mucosa. Gastroenterol. Jpn 1992, 27, 466–472. [Google Scholar] [CrossRef]
  25. Rosenstock, S.; Jørgensen, T.; Bonnevie, O.; Andersen, L. Risk factors for peptic ulcer disease: A population based prospective cohort study comprising 2416 Danish adults. Gut 2003, 52, 186–193. [Google Scholar] [CrossRef]
  26. Chou, S.P. An Examination of the Alcohol Consumption and Peptic Ulcer Association—Results of a National Survey. Alcohol. Clin. Exp. Res. 1994, 18, 149–153. [Google Scholar] [CrossRef]
  27. Park, H.; Cho, D.; Huang, E.; Seo, J.Y.; Kim, W.G.; Todorov, S.D.; Ji, Y.; Holzapfel, W.H. Amelioration of Alcohol Induced Gastric Ulcers Through the Administration of Lactobacillus plantarum APSulloc 331261 Isolated From Green Tea. Front. Microbiol. 2020, 11, 420. [Google Scholar] [CrossRef] [Green Version]
  28. Oliveira Fde, A.; Andrade, L.N.; de Sousa, E.B.; de Sousa, D.P. Anti-ulcer activity of essential oil constituents. Molecules 2014, 19, 5717–5747. [Google Scholar] [CrossRef] [Green Version]
  29. Eftekhari, M.; Hoseinsalari, A.; Mansourian, M.; Farjadmand, F.; Shams Ardekani, M.R.; Sharifzadeh, M.; Hassanzadeh, G.; Khanavi, M.; Gholami, M. Trachyspermum ammi (L.) Sprague, superb essential oil and its major components on peptic ulcers: In vivo combined in silico studies. Daru 2019, 27, 317–327. [Google Scholar] [CrossRef]
  30. Caldas, G.F.R.; Oliveira, A.R.d.S.; Araújo, A.V.; Quixabeira, D.C.A.; Silva-Neto, J.d.C.; Costa-Silva, J.H.; de Menezes, I.R.A.; Ferreira, F.; Leite, A.C.L.; da Costa, J.G.M.; et al. Gastroprotective and Ulcer Healing Effects of Essential Oil of Hyptis martiusii Benth. (Lamiaceae). PLoS ONE 2014, 9, e84400. [Google Scholar] [CrossRef]
  31. Adinortey, M.B.; Ansah, C.; Galyuon, I.; Nyarko, A. In vivo models used for evaluation of potential antigastroduodenal ulcer agents. Ulcers 2013, 2013, 796405. [Google Scholar] [CrossRef]
  32. Hajrezaie, M.; Golbabapour, S.; Hassandarvish, P.; Gwaram, N.S.; A. Hadi, A.H.; Mohd Ali, H.; Majid, N.; Abdulla, M.A. Acute Toxicity and Gastroprotection Studies of a New Schiff Base Derived Copper (II) Complex against Ethanol-Induced Acute Gastric Lesions in Rats. PLoS ONE 2012, 7, e51537. [Google Scholar] [CrossRef] [Green Version]
  33. Hajrezaie, M.; Salehen, N.; Karimian, H.; Zahedifard, M.; Shams, K.; Batran, R.A.; Majid, N.A.; Khalifa, S.A.M.; Ali, H.M.; El-Seedi, H.; et al. Biochanin A Gastroprotective Effects in Ethanol-Induced Gastric Mucosal Ulceration in Rats. PLoS ONE 2015, 10, e0121529. [Google Scholar] [CrossRef] [Green Version]
  34. Rahman, Z.; Dwivedi, D.K.; Jena, G.B. Ethanol-induced gastric ulcer in rats and intervention of tert-butylhydroquinone: Involvement of Nrf2/HO-1 signalling pathway. Hum. Exp. Toxicol. 2020, 39, 547–562. [Google Scholar] [CrossRef]
  35. Lebda, M.A.; Mostafa, R.E.; Taha, N.M.; Abd El-Maksoud, E.M.; Tohamy, H.G.; Al Jaouni, S.K.; El-Far, A.H.; Elfeky, M.S. Commiphora myrrh Supplementation Protects and Cures Ethanol-Induced Oxidative Alterations of Gastric Ulceration in Rats. Antioxidants 2021, 10, 1836. [Google Scholar] [CrossRef]
  36. Chou, S.T.; Peng, H.Y.; Hsu, J.C.; Lin, C.C.; Shih, Y. Achillea millefolium L. essential oil inhibits LPS-induced oxidative stress and nitric oxide production in RAW 264.7 Macrophages. Int. J. Mol. Sci. 2013, 14, 12978–12993. [Google Scholar] [CrossRef] [Green Version]
  37. Mohan, S.; Hobani, Y.H.; Shaheen, E.; Abou-Elhamd, A.S.; Abdelhaleem, A.; Alhazmi, H.A.; Abdelwahab, S.I. Ameliorative effect of Boesenbergin A, a chalcone isolated from Boesenbergia rotunda (Fingerroot) on oxidative stress and inflammation in ethanol-induced gastric ulcer in vivo. J. Ethnopharmacol. 2020, 261, 113104. [Google Scholar] [CrossRef]
  38. Al-Sayed, E.; El-Naga, R.N. Protective role of ellagitannins from Eucalyptus citriodora against ethanol-induced gastric ulcer in rats: Impact on oxidative stress, inflammation and calcitonin-gene related peptide. Phytomedicine 2015, 22, 5–15. [Google Scholar] [CrossRef]
  39. Guslandi, M. Effects of Ethanol on the Gastric Mucosa. Dig. Dis. 1987, 5, 21–32. [Google Scholar] [CrossRef]
  40. Yu, L.; Li, R.; Liu, W.; Zhou, Y.; Li, Y.; Qin, Y.; Chen, Y.; Xu, Y. Protective Effects of Wheat Peptides against Ethanol-Induced Gastric Mucosal Lesions in Rats: Vasodilation and Anti-Inflammation. Nutrients 2020, 12, 2355. [Google Scholar] [CrossRef]
  41. Shin, M.S.; Lee, J.; Lee, J.W.; Park, S.H.; Lee, I.K.; Choi, J.A.; Lee, J.S.; Kang, K.S. Anti-Inflammatory Effect of Artemisia argyi on Ethanol-Induced Gastric Ulcer: Analytical, In Vitro and In Vivo Studies for the Identification of Action Mechanism and Active Compounds. Plants 2021, 10, 332. [Google Scholar] [CrossRef] [PubMed]
  42. Tarnawski, A.S. Cellular and Molecular Mechanisms of Gastrointestinal Ulcer Healing. Dig. Dis. Sci. 2005, 50, S24–S33. [Google Scholar] [CrossRef] [PubMed]
  43. Boby, N.; Abbas, M.A.; Lee, E.B.; Im, Z.E.; Hsu, W.H.; Park, S.C. Protective Effect of Pyrus ussuriensis Maxim. Extract against Ethanol-Induced Gastritis in Rats. Antioxidants 2021, 10, 439. [Google Scholar] [CrossRef] [PubMed]
  44. Sánchez-Mendoza, M.E.; López-Lorenzo, Y.; Cruz-Antonio, L.; Matus-Meza, A.-S.; Sánchez-Mendoza, Y.; Arrieta, J. Gastroprotection of Calein D against Ethanol-Induced Gastric Lesions in Mice: Role of Prostaglandins, Nitric Oxide and Sulfhydryls. Molecules 2019, 24, 622. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Al-Quraishy, S.; Othman, M.S.; Dkhil, M.A.; Abdel Moneim, A.E. Olive (Olea europaea) leaf methanolic extract prevents HCl/ethanol-induced gastritis in rats by attenuating inflammation and augmenting antioxidant enzyme activities. Biomed. Pharmacother. 2017, 91, 338–349. [Google Scholar] [CrossRef] [PubMed]
  46. Hossen, M.A.; Reza, A.; Ahmed, A.M.A.; Islam, M.K.; Jahan, I.; Hossain, R.; Khan, M.F.; Maruf, M.R.A.; Haque, M.A.; Rahman, M.A. Pretreatment of Blumea lacera leaves ameliorate acute ulcer and oxidative stress in ethanol-induced Long-Evan rat: A combined experimental and chemico-biological interaction. Biomed. Pharmacother. 2021, 135, 111211. [Google Scholar] [CrossRef]
  47. Song, S.H.; Kim, J.E.; Sung, J.E.; Lee, H.A.; Yun, W.B.; Lee, Y.H.; Song, H.; Hwang, D. Anti-ulcer effect of Gallarhois extract with anti-oxidant activity in an ICR model of ethanol/hydrochloride acid-induced gastric injury. J. Tradit. Complement. Med. 2019, 9, 372–382. [Google Scholar] [CrossRef]
  48. Hu, J.; Liu, R.; Yu, X.; Li, Z.; Liu, X.; Hao, Y.; Zhu, N.; Kang, J.; Li, Y. Protective Effects of Small-Molecule Oligopeptides Isolated from Tilapia Fish Scale on Ethanol-Induced Gastroduodenal Injury in Rats. Nutrients 2021, 13, 2078. [Google Scholar] [CrossRef]
  49. Gamal El-Din, M.I.; Youssef, F.S.; Ashour, M.L.; Eldahshan, O.A.; Singab, A.N.B. New γ-pyrone glycoside from Pachira glabra and assessment of its gastroprotective activity using an alcohol-induced gastric ulcer model in rats. Food Funct. 2020, 11, 1958–1965. [Google Scholar] [CrossRef]
  50. Kan, J.; Hood, M.; Burns, C.; Scholten, J.; Chuang, J.; Tian, F.; Pan, X.; Du, J.; Gui, M. A Novel Combination of Wheat Peptides and Fucoidan Attenuates Ethanol-Induced Gastric Mucosal Damage through Anti-Oxidant, Anti-Inflammatory, and Pro-Survival Mechanisms. Nutrients 2017, 9, 978. [Google Scholar] [CrossRef] [Green Version]
  51. Farooq, U.; Khan, T.; Shah, S.A.; Hossain, M.S.; Ali, Y.; Ullah, R.; Raziq, N.; Shahid, M.; Capasso, R. Isolation, Characterization and Neuroprotective Activity of Folecitin: An In Vivo Study. Life 2021, 11, 825. [Google Scholar] [CrossRef]
  52. Safayhi, H.; Sabieraj, J.; Sailer, E.R.; Ammon, H.P. Chamazulene: An antioxidant-type inhibitor of leukotriene B4 formation. Planta Med. 1994, 60, 410–413. [Google Scholar] [CrossRef]
  53. Tambe, Y.; Tsujiuchi, H.; Honda, G.; Ikeshiro, Y.; Tanaka, S. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Med. 1996, 62, 469–470. [Google Scholar] [CrossRef]
  54. Del-Vechio-Vieira, G.; Sousa, O.; Miranda, M.; Senna-Valle, L.; Kaplan, M. Analgesic and Anti-inflammatory Properties of Essential Oil from Ageratum fastigiatum. Braz. Arch. Biol. Technol. 2009, 52, 1115–1121. [Google Scholar] [CrossRef]
  55. Sitarek, P.; Rijo, P.; Garcia, C.; Skała, E.; Kalemba, D.; Białas, A.J.; Szemraj, J.; Pytel, D.; Toma, M.; Wysokińska, H.; et al. Antibacterial, Anti-Inflammatory, Antioxidant, and Antiproliferative Properties of Essential Oils from Hairy and Normal Roots of Leonurus sibiricus L. and Their Chemical Composition. Oxid. Med. Cell. Longev. 2017, 2017, 7384061. [Google Scholar] [CrossRef] [Green Version]
  56. Valente, J.; Zuzarte, M.; Gonçalves, M.J.; Lopes, M.C.; Cavaleiro, C.; Salgueiro, L.; Cruz, M.T. Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil. Food Chem. Toxicol. 2013, 62, 349–354. [Google Scholar] [CrossRef]
  57. Zou, L.; Zhang, Y.; Li, W.; Zhang, J.; Wang, D.; Fu, J.; Wang, P. Comparison of Chemical Profiles, Anti-Inflammatory Activity, and UPLC-Q-TOF/MS-Based Metabolomics in Endotoxic Fever Rats between Synthetic Borneol and Natural Borneol. Molecules 2017, 22, 1446. [Google Scholar] [CrossRef] [Green Version]
  58. Biswas, K.; Bandyopadhyay, U.; Chattopadhyay, I.; Varadaraj, A.; Ali, E.; Banerjee, R.K. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. 2003, 278, 10993–11001. [Google Scholar] [CrossRef] [Green Version]
  59. Corne, S.J.; Morrissey, S.M.; Woods, R.J. Proceedings: A method for the quantitative estimation of gastric barrier mucus. J. Physiol. 1974, 242, 116–117. [Google Scholar]
  60. Mohamed, M.E.; Kandeel, M.; Abd El-Lateef, H.M.; El-Beltagi, H.S.; Younis, N.S. The Protective Effect of Anethole against Renal Ischemia/Reperfusion: The Role of the TLR2,4/MYD88/NFκB Pathway. Antioxidants 2022, 11, 535. [Google Scholar] [CrossRef]
Molecules 27 07908 g001 550
Figure 1. The actions of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on (a) demonstrative images of the separated gastric and (b) gastric injury scores. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA afterward Tukey’s post hoc test (p < 0.05).
Figure 1. The actions of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on (a) demonstrative images of the separated gastric and (b) gastric injury scores. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA afterward Tukey’s post hoc test (p < 0.05).
Molecules 27 07908 g001
Molecules 27 07908 g002 550
Figure 2. The actions of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on (a) histological assessment of the gastric tissue staining with H&E and the scores for (b) hemorrhagic injury, (c) epithelial cell loss, and (d) edema with leucocytes. Blue arrows show necrotic lesions, black arrowheads display disrupted surface epithelium and green arrowheads indicate leucocyte infiltration. (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol.
Figure 2. The actions of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on (a) histological assessment of the gastric tissue staining with H&E and the scores for (b) hemorrhagic injury, (c) epithelial cell loss, and (d) edema with leucocytes. Blue arrows show necrotic lesions, black arrowheads display disrupted surface epithelium and green arrowheads indicate leucocyte infiltration. (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol.
Molecules 27 07908 g002
Molecules 27 07908 g003 550
Figure 3. Effects of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on immunohistochemical analysis of (a) Nrf2 and HO-1 expressions, immunohistochemical scores for (b) Nrf2 and (c) HO1 and on the gene expression of (d) Nrf2 and (e) HO1. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA after Tukey’s post hoc test (p < 0.05).
Figure 3. Effects of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on immunohistochemical analysis of (a) Nrf2 and HO-1 expressions, immunohistochemical scores for (b) Nrf2 and (c) HO1 and on the gene expression of (d) Nrf2 and (e) HO1. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA after Tukey’s post hoc test (p < 0.05).
Molecules 27 07908 g003
Molecules 27 07908 g004 550
Figure 4. Effects of YEO (100 and 200 mg/kg) administration in acute gastric injuries induced by ethanol on serum inflammatory cytokines markers including (a) IL-1β, (b) IL-6, and (c) TNF-α and on gastric mucosa defensive factors including (d) PEG2, (e) serum NO, and (f) gastric NO. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA after Tukey’s post hoc test (p < 0.05).
Figure 4. Effects of YEO (100 and 200 mg/kg) administration in acute gastric injuries induced by ethanol on serum inflammatory cytokines markers including (a) IL-1β, (b) IL-6, and (c) TNF-α and on gastric mucosa defensive factors including (d) PEG2, (e) serum NO, and (f) gastric NO. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA after Tukey’s post hoc test (p < 0.05).
Molecules 27 07908 g004
Molecules 27 07908 g005 550
Figure 5. Effects of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on gastric and serum of (a,b) MDA, (c,d) GSH, (e,f) SOD and (g,h) catalase, respectively. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA afterward Tukey’s post hoc test (p < 0.05).
Figure 5. Effects of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced by ethanol in rats on gastric and serum of (a,b) MDA, (c,d) GSH, (e,f) SOD and (g,h) catalase, respectively. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA afterward Tukey’s post hoc test (p < 0.05).
Molecules 27 07908 g005
Molecules 27 07908 g006 550
Figure 6. Effects of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced via ethanol in rats on apoptotic indicators including (a) caspase-3, (b) caspase-3 and 9, and the gene expression of (c) Bax and (d) Bcl2. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA afterwards Tukey’s post hoc test (p < 0.05).
Figure 6. Effects of YEO (100 and 200 mg/kg) administration in acute gastric mucosal injuries induced via ethanol in rats on apoptotic indicators including (a) caspase-3, (b) caspase-3 and 9, and the gene expression of (c) Bax and (d) Bcl2. All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA afterwards Tukey’s post hoc test (p < 0.05).
Molecules 27 07908 g006
Table
Table 1. The actions of the YEO on gastric ulcer area, inhibition % and Alcian blue binding ability in various experimental groups.
Table 1. The actions of the YEO on gastric ulcer area, inhibition % and Alcian blue binding ability in various experimental groups.
Animal’s GroupUlcer Area (mm2)Inhibition (%)mg Alcian Blue/g Tissue
Control--620.75 ± 15.23
Ethanol735.8 ± 30.7 #-156.35 ± 10.41 #
YEO (100 mg/kg) + ethanol360.49 ± 10.76 *52.6% *340.95 ± 13.72 *
YEO (200 mg/kg) + ethanol241.56 ±13.68 *64.28% *448.93 ± 13.6 *
Lansoprazole + ethanol192.45 ±15.32 *€70.16% *€571.8 ± 21.5 *€
All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA after Tukey’s post hoc test (p < 0.05).
Table
Table 2. Effect of yarrow oil on gastric pH and volume and pepsin activity of gastric juice in various experimental groups.
Table 2. Effect of yarrow oil on gastric pH and volume and pepsin activity of gastric juice in various experimental groups.
Animal’s GroupGastric pHGastric Volume (mL)Pepsin Activity (U/mL)
Control6.3 ± 1.590.14 ± 0.032857.50 ± 202.84
Ethanol4.35 ± 0.47 #2.85 ± 0.74 #1046.33 ± 178.03 #
YEO (100 mg/kg) + ethanol5.39 ± 2.23 *2.01 ± 0.24 *1352.00 ± 140.94 *
YEO (200 mg/kg) + ethanol5.7 ± 2.43 *1.81 ± 0.31 *1727.76 ± 151.09 *
Lansoprazole + ethanol6.01 ± 0.51 *€1.27 ± 0.42 *€2092.13 ± 145.82 *€
All data are quantified as mean ± SE, (n = 6). (#) defines statistically significant related to the control, (*) signifies statistically significant related to the ethanol-induced gastric mucosal injuries, and (€) designates statistically significant related to YEO 200 + ethanol via one-way ANOVA after Tukey’s post hoc test (p < 0.05).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alomair, M.K.; Alabduladheem, L.S.; Almajed, M.A.; Alobaid, A.A.; Alkhalifah, E.A.R.; Younis, N.S.; Mohamed, M.E. Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway. Molecules 2022, 27, 7908. https://doi.org/10.3390/molecules27227908

AMA Style

Alomair MK, Alabduladheem LS, Almajed MA, Alobaid AA, Alkhalifah EAR, Younis NS, Mohamed ME. Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway. Molecules. 2022; 27(22):7908. https://doi.org/10.3390/molecules27227908

Chicago/Turabian Style

Alomair, Manar K., Lama S. Alabduladheem, Marwah A. Almajed, Amjad A. Alobaid, Essraa A. R. Alkhalifah, Nancy S. Younis, and Maged E. Mohamed. 2022. "Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway" Molecules 27, no. 22: 7908. https://doi.org/10.3390/molecules27227908

APA Style

Alomair, M. K., Alabduladheem, L. S., Almajed, M. A., Alobaid, A. A., Alkhalifah, E. A. R., Younis, N. S., & Mohamed, M. E. (2022). Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway. Molecules, 27(22), 7908. https://doi.org/10.3390/molecules27227908

Article Metrics

Back to TopTop